TITLE

The Safety, Tolerability and Risks Associated with the Use of Newer Generation Antidepressant Drugs: A Critical Review of the Literature

PUB. DATE
October 2016
SOURCE
NAPPP Monthly Newsletter;Oct2016, Vol. 11 Issue 10, p8
SOURCE TYPE
Periodical
DOC. TYPE
Article
ABSTRACT
The article presents a study which examined the safety, tolerability, and risks related to the use of newer generation of antidepressant drugs (AD) for the treatment of major depressive disorders. Among the drugs are serotonin noradrenaline reuptake inhibitors, bupropion, and mirtazapine. Also cited are some possible side effects like gastrointestinal symptoms, weight gain, and metabolic abnormalities.
ACCESSION #
118931156

 

Related Articles

  • SEROTONIN & NOREPINEPHRINE REUPTAKE INHIBITORS (SNRIs).  // Complete Guide to Prescription & Nonprescription Drugs 2012;2012, p746 

    The article presents information on the antidepressant serotonin and norepinephrine reuptake inhibitors (SNRI), including their dosage, usage, adverse reactions, side effects, precautions when administering, and possible interaction with other drugs.

  • Depression treatment update. Shah, Monica // Drug Topics;Sep2011, Vol. 155 Issue 9, p42 

    The article reports on the results of the CO-MED study which focuses on the use of monotherapy and combination drugs in treating patients with major depressive disorder (MDD). Megan Maroney, clinical assistant professor at Ernest Mario College of Pharmacy, notes that the use of mirtazapine plus...

  • SELECTIVE SEROTONIN REUPTAKE INHIBITORS (SSRIs).  // Complete Guide to Prescription & Nonprescription Drugs 2012;2012, p742 

    The article presents information on selective serotonin reuptake inhibitors (SSRI), which are antidepressant, antiobsessional and antianxiety agents, including their dosage, usage, adverse reactions, side effects, precautions, and possible interaction with other drugs.

  • Dense Cranial Electroacupuncture Stimulation for Major Depressive Disorder–A Single-Blind, Randomized, Controlled Study Zhang, Zhang-Jin; Ng, Roger; Man, Sui Cheung; Li, Tsui Yin Jade; Wong, Wendy; Tan, Qing-Rong; Wong, Hei Kiu; Chung, Ka-Fai; Wong, Man-Tak; Tsang, Wai-Kiu Alfert; Yip, Ka-chee; Ziea, Eric; Wong, Vivian Taam // PLoS Clinical Trials;Jan2012, Vol. 7 Issue 1, p1 

    Background: Previous studies suggest that electroacupuncture possesses therapeutic benefits for depressive disorders. The purpose of this study was to determine whether dense cranial electroacupuncture stimulation (DCEAS) could enhance the antidepressant efficacy in the early phase of selective...

  • The Monoamine Oxidase Inhibitors: Relics Reconsidered. O'Brien, Virginia // Psychiatric Annals;Mar2011, Vol. 41 Issue 3, p176 

    The article evaluates the potential of monoamine oxidase inhibitors (MAOIs) in fighting depression. Their mood-improving attributes were found in the 1950s through iproniazid, a drug used in treating tuberculosis and can enhance the emotions of patients, although MAOIs became less popular...

  • Exploring the effects of depression and treatment of depression in reinforcement learning. Castro-Rodrigues, Pedro; Oliveira-Maia, Albino J. // Frontiers in Integrative Neuroscience;Oct2013, Vol. 7, p1 

    The authors discuss a study regarding the impact of major depressive disorder (MDD) and the use of a selective serotonin reuptake inhibitor (SSRI) to treat MDD on reinforcement learning. They find that the anti-depressant effects of drugs modulating serotonergic neurotransmission indicate the...

  • SSRIs associated with loss of BMD in older men.  // Reactions Weekly;12/4/2010, Issue 1330, p4 

    The article discusses a research study on the association of selective serotonin reuptake inhibitors (SSRI) use with an increased loss of bone mineral density (BMD) among older men, presented at the 32nd Annual Meeting of the American Society for Bone and Mineral Research.

  • cne QUIZ.  // Journal of Gerontological Nursing;Apr2010, Vol. 36 Issue 4, p28 

    A quiz concerning side effects of selective serotonin reuptake inhibitors (SSRIs) is presented.

  • Newer antidepressants for the treatment of depression in adults. Hatcher, Simon; Arroll, Bruce // BMJ: British Medical Journal (Overseas & Retired Doctors Edition;1/28/2012, Vol. 344 Issue 7841, p45 

    The article presents an overview of antidepressants which have been associated to cause psychological dependence, particularly the selective serotonin reuptake inhibitors (SSRIs) in Great Britain. It mentions the recommendation from the National Institute for Health and Clinical Excellence...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics